Caeli Nova, breathing technology innovator operating at the intersection of aviation and healthcare, has successfully completed a second closing of its Series A round of financing, adding a further CHF 2m of investment to its CHF 8m first closing in December 2021.
This second closing brings the Series A investment in Caeli Nova to a total of CHF 10m, setting the company on a strong path to installing Cordillera, Caeli Nova’s launch product, onto its first aircraft during 2022 and further developing its technology to advance a long-overlooked aspect of aviation.
The investment round was syndicated by LG Capital, Switzerland-based venture builder and co-founder of Caeli Nova. As part of the second closing, Caeli Nova welcomed Swiss entrepreneur and investor Daniel S. Aegerter of Armada Investment. Within its venture portfolio, Armada has experience with multiple aviation innovators, such as Flytrex and Lilium.
Tim Wakeford, CEO of Caeli Nova says: “We are very pleased to welcome Daniel as a new shareholder, who is an experienced partner known for investing in visionary entrepreneurs who focus on unique ideas and meaningful innovation.”
Among Caeli Nova’s Series A investors, Armada joins this round’s lead investor Ornament Health, a Swiss digital health company, and Latécoère, a leading stock market listed Tier 1 aerospace manufacturer.
Wakeford adds: “The funding we’ve received in our Series A round has come from both the healthcare and aviation sectors, which truly speaks to the vision we share with our partners for Caeli Nova’s technology. This support brings us closer to installing our product initially in the aviation market and will also allow us to further explore possibilities in other sectors.”
Cordillera, Caeli Nova’s launch product, is an onboard emergency oxygen system that enables aircraft to overcome limitations associated with existing systems, enabling aircraft to fly the most direct routes, and significantly reducing costs and carbon emissions for airlines.
About Caeli Nova:
Caeli Nova’s patented breathing technology can improve oxygenation of the human body in demanding situations such as altitude.
Caeli Nova’s first product, Cordillera, is an emergency oxygen system suitable for commercial and military passenger aircraft. This key safety system is designed to protect passengers in the rare event of a loss of cabin pressure, known as a decompression. In addition, Cordillera removes operational constraints and limitations facing airlines, airframers and defence aerospace today, thereby allowing airlines to operate shorter flights, with associated reductions in fuel and carbon emissions.
About LG Capital:
LG Capital AG, led by its founder & serial entrepreneur Leo Grünstein and its Managing Director Övünç Okyay, is a Switzerland-based venture builder that teams up with strong founding teams to realize big-idea ventures from scratch. It creates ventures from the ground up as co-founder with a 7-10+ year time horizon and supports them from foundation in the fields of C-level team building, strategy & business planning, fundraising, international expansion, corporate finance, and best practice sharing.
About Ornament Health:
Ornament Health AG is a Swiss company developing the app Ornament. Based on the principles of preventative medicine, the app helps users around the world to monitor their health, download test results, and track the dynamics and analytics of biomarkers. Ornament Health was founded in 2019 and has dynamically developed health solutions by bringing together experts in the fields of medicine and technology. Since launching its app in late 2019, Ornament has now achieved an active monthly audience of more than 100’000 users.
About Armada Investment:
Armada is a Zurich-based entrepreneurial driven investment firm. Lead by Daniel S. Aegerter, Armada provides founder capital to ambitious and visionary entrepreneurs. Founded in 2000, Armada pursues the most promising companies and investments in private equity, public market securities and real estate. Among others, Daniel has been an early backer of Flytrex, Lilium and numerous other ventures working on breakthrough technologies
Featured image credited to Caeli Nova
